API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.globenewswire.com//news-release/2023/12/09/2793449/35575/en/Aptose-Tuspetinib-Clinical-Data-Featured-in-Oral-Presentation-at-the-2023-ASH-Annual-Meeting.html
https://www.globenewswire.com//news-release/2023/11/02/2772405/35575/en/Aptose-Tuspetinib-Clinical-Data-Selected-for-Oral-Presentation-at-the-2023-ASH-Annual-Meeting.html
https://www.globenewswire.com//news-release/2023/10/30/2769327/35575/en/Aptose-Presents-Highlights-from-Clinical-Update-Webcast-Featuring-Latest-Available-Data-on-AML-Drug-Tuspetinib.html
https://www.globenewswire.com//news-release/2023/10/23/2764610/35575/en/Aptose-to-Hold-Clinical-Update-and-KOL-Data-Review-of-AML-Drug-Tuspetinib-on-Monday-October-30th.html